Pasithea Therapeutics Net Profit Margin Growth & History (KTTA)
Pasithea Therapeutics's net profit margin was −2,864.29% for fiscal 2022.
View full Pasithea Therapeutics company overviewPasithea Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −2,864.29% | +11566.21 pp |
| 2021 | 2021-12-31 | −14,430.49% | — |
Pasithea Therapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −2,126.06% | — |
| Q3 2022 | 2022-09-30 | −2,097.88% | — |
| Q2 2022 | 2022-06-30 | −19,574.36% | — |
| Q1 2022 | 2022-03-31 | −11,526.14% | — |
Pasithea Therapeutics net profit margin trends
Between the periods ended 2021-12-31 and 2022-12-31, Pasithea Therapeutics's net profit margin increased from −14,430.49% to −2,864.29%, a change of +11566.21 percentage points. The latest reported quarter, Q4 2022, shows −2,126.06%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pasithea Therapeutics source filings ↗